Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market By Product Type( Stent , PTA Balloon Catheter) By Diagnosis/Imaging Techniques(High-definition MRI, Balloon test occlusion, Computed tomographic angiogram (CTA), Transcranial Doppler ultrasound (TCD), Digital subtraction angiography (DSA), Others) By End Users( Hospitals, Clinics, Diagnostic Centres, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In the last few years, due to the sedentary lifestyle and urbanization a huge population is suffering from cerebrovascular diseases. Intracranial Atherosclerotic Disease (ICAD) is one amongst the prelevant disease wherein blockage, malformation, or hemorrhage prevents the brain cells from getting enough oxygen leading to brain damage. When plaque (cholesterol, fatty deposits, and other substances) builds up in the blood vessels at the base of the brain, it narrows and hardens, creating intracranial atherosclerotic disease. This condition is also mentioned to as atherosclerosis, stenosis or toughening of the arteries. A stroke can occur when an artery narrows to the point that blood flow to the brain is restricted. Strokes can be caused by blood clots or bleeding (haemorrhage), which deprives brain cells of oxygen and causes them to die. Stroke is believed to be due to intracranial atherosclerotic disease, which is the most prevalent cause of stroke globally. In the last few years, diagnostic and treatment options for intracranial atherosclerotic disease (ICAD) have risen. In the implementation of precision medicine for ICAD, concrete initiatives have evolved, centering individualised treatment for the prevention of stroke and cognitive impairment around pathology. Additionally the diagnosis for intracranial atherosclerotic disease is very critical which has gained huge importance for the scope of treatment. Various high technology based diagnosis techniques such as high definition MRI can detect vessel wall lesions, both stenotic and nonstenotic. Recent imaging technologies, such as optical coherence tomography and other modalities, are reviewed to screen the intracranial arteries for symptomatic ICAD, not only to diagnose ICAD, but also to establish if ICAD plaques have any high-risk traits that should be treated. Potential future developments for the treatment of ICAD such as new iterations of self-expanding intracranial stents with better delivery systems, and the development of trackable drug-coated balloons for the cerebral circulation to treat primary stages of ICAD has led to a tremendous growth in the global intracranial atherosclerotic disease (ICAD) pathology market globally.
In terms of revenue, global intracranial atherosclerotic disease (ICAD) pathology market is growing at a CAGR of 5.62% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market Revenue & Forecast, (US$ Million), 2015 – 2030
Product Type Outlook:
Based on the type, the global intracranial atherosclerotic disease (ICAD) pathology market is segmented into stent and PTA Balloon Catheter. Intracranial stents are small mesh tubes that are permanently implanted in the brain to unblock clogged arteries and enhance blood flow. Over the last decade, endovascular revascularization of damaged intracranial arteries using stents has grown popular as a way to improve the poor outcomes associated with symptomatic ICAD. Stenting is sometimes done in conjunction with balloon angioplasty to prevent plaque recoiling and to cover a plaque or an intimal flap. It may also help to prevent vascular dissection. The first intracranial stenting stent was a balloon-expandable stent that performed well in the SSYLVIA clinical study (Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries), but it was never manufactured or marketed. Later on the Wingspan stent was the first self-expanding stent designed exclusively for symptomatic ICAD treatment. It is currently the only stent approved by the Food and Drug Administration (FDA) for the treatment of symptomatic intracranial ICAD. According to the American Heart Association (AHA) it was studied that the stent appeared to cut risk to 50 percent and lower the risk of recurrent stroke or death in the patients.
Diagnosis/Imaging Techniques Outlook:
Based on diagnosis/imaging techniques, the intracranial atherosclerotic disease (ICAD) pathology market is segmented into high-definition MRI, balloon test occlusion, computed tomographic angiogram (CTA), transcranial doppler ultrasound (TCD), digital subtraction angiography (DSA) and others. CT (computerized tomography) angiography has gradually replaced invasive traditional angiography as the main technique for diagnosing and characterisation of most neurovascular disorders. A specific dye is injected into the patient's circulation, allowing the doctor to view blood flow on a CT scan, which is known as a computed tomographic angiography (CTA). Over the last few years, there have been advanced technologies that are being incorporated into diagnosis techniques to have precision results for better treatment for intracranial atherosclerotic disease (ICAD). Moreover hospitals and diagnostic centers are looking forward to invest in advanced diagnosis techniques such as 3-D imaging with rotational angiography which uses a quick spin around the patient to create a computed tomography (CT). Thus with such advancements in the diagnosis and imaging techniques the global intracranial atherosclerotic disease (ICAD) pathology market is experiencing tremendous growth.
Region Outlook:
Based on the regions, North America had the highest share in the intracranial atherosclerotic disease (ICAD) pathology market in the year 2021. Stroke is one amongst the prominent causes of death and morbidity in the United States. Large artery atherosclerosis causes almost 20% of ischemic strokes, with over half of those occurring intracranially, and it has a high recurrence rate despite medical treatment. In the last few years there have been technological advancements and huge investments in the diagnosis and medical treatment for intracranial atherosclerotic disease in United States and Canada. Moreover the presence of key players including Boston Scientific Corporation and others are contributing to the advancements and innovations in the products and equipment required for imaging and diagnosis of intracranial atherosclerotic disease. Furthermore, there has been rise in the research and development for the treatment technologies of ICAD which has led to the growth in intracranial atherosclerotic disease (ICAD) pathology market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global intracranial atherosclerotic disease (ICAD) pathology market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global intracranial atherosclerotic disease (ICAD) pathology market are listed below:
- Acandis GmbH
- BALT group.
- Boston Scientific Corporation
- CERENOVUS
- Medtronic
- MicroPort Scientific Corporation
- Stryker
- Terumo Corporation
- Other Market Participants
Global Intracranial Atherosclerotic Disease (ICAD) Pathology Market:
By Product Type
- Stent
- PTA Balloon Catheter
By Diagnosis/imaging techniques
- High-definition MRI
- Balloon test occlusion
- Computed tomographic angiogram (CTA)
- Transcranial Doppler ultrasound (TCD)
- Digital subtraction angiography (DSA)
- Others
By End Users
- Hospitals
- Clinics
- Diagnostic centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1.
Market
Segmentation
1.2.
Years
Considered
1.2.1.
Historic
Years: 2015 - 2021
1.2.2.
Base
Year: 2021
1.2.3.
Forecast
Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1.
Primary
Research
3.1.1.
Research
Questionnaire
3.1.2.
Global
Percentage Breakdown
3.1.3.
Primary
Interviews: Key Opinion Leaders (KOLs)
3.2.
Secondary
Research
3.2.1.
Paid
Databases
3.2.2.
Secondary
Sources
3.3.
Market
Size Estimates
3.3.1.
Top-Down
Approach
3.3.2.
Bottom-Up
Approach
3.4.
Data
Triangulation Methodology
3.5.
Research
Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Intracranial Atherosclerotic Disease (ICAD) Pathology Market
6.
Market
Synopsis: Intracranial Atherosclerotic
Disease (ICAD) Pathology Market
7.
Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Analysis: Qualitative
Perspective
7.1.
Introduction
7.1.1.
Product
Definition
7.1.2.
Industry
Development
7.2.
Market
Dynamics
7.2.1.
Drivers
7.2.2.
Restraints
7.2.3.
Opportunities
7.2.4.
Challenges
7.3.
Trends
in Intracranial Atherosclerotic Disease (ICAD) Pathology Market
7.4.
Market Determinants
Radar Chart
7.5.
Macro-Economic
and Micro-Economic Indicators: Intracranial Atherosclerotic Disease (ICAD)
Pathology Market
7.6.
Porter’s
Five Force Analysis
7.7.
Impact
of Covid-19 on Intracranial Atherosclerotic Disease (ICAD) Pathology Market
8.
Global Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 –
2030
8.1.
Overview
8.1.1.
Global Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn)
8.2.
Global Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Product Type
8.2.1.
Stent
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 - 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 - 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 - 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 - 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 - 2030
8.2.2.
PTA
Balloon Catheter
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 - 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 - 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 - 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 - 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 - 2030
8.3.
Key
Segment for Channeling Investments
8.3.1.
By
Product Type
9.
Global Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 –
2030
9.1.
Overview
9.2.
Global Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Diagnosis/imaging techniques
9.2.1.
High
Definition MRI
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 - 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 - 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 - 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 - 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 - 2030
9.2.2.
Balloon
test occlusion
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.2.3.
Computed
tomographic angiogram (CTA)
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 - 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 - 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 - 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 - 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 - 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 - 2030
9.2.4.
Transcranial
Doppler ultrasound (TCD)
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.4.3.
Market
Forecast, 2022 - 2030
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 - 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 - 2030
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 - 2030
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 - 2030
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 - 2030
9.2.5.
Digital
subtraction angiography (DSA)
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.5.3.
Market
Forecast, 2022 - 2030
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North
America
9.2.5.5.1.1. Market Estimation, 2015 - 2021
9.2.5.5.1.2. Market Forecast, 2022 - 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2021
9.2.5.5.2.2. Market Forecast, 2022 - 2030
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2021
9.2.5.5.3.2. Market Forecast, 2022 - 2030
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2021
9.2.5.5.4.2. Market Forecast, 2022 - 2030
9.2.5.5.5.
Latin
America
9.2.5.5.5.1. Market Estimation, 2015 - 2021
9.2.5.5.5.2. Market Forecast, 2022 - 2030
9.2.6.
Others
9.2.6.1.
Definition
9.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.6.3.
Market
Forecast, 2022 - 2030
9.2.6.4.
Compound
Annual Growth Rate (CAGR)
9.2.6.5.
Regional
Bifurcation
9.2.6.5.1.
North
America
9.2.6.5.1.1. Market Estimation, 2015 - 2021
9.2.6.5.1.2. Market Forecast, 2022 - 2030
9.2.6.5.2.
Europe
9.2.6.5.2.1. Market Estimation, 2015 - 2021
9.2.6.5.2.2. Market Forecast, 2022 - 2030
9.2.6.5.3.
Asia
Pacific
9.2.6.5.3.1. Market Estimation, 2015 - 2021
9.2.6.5.3.2. Market Forecast, 2022 - 2030
9.2.6.5.4.
Middle
East and Africa
9.2.6.5.4.1. Market Estimation, 2015 - 2021
9.2.6.5.4.2. Market Forecast, 2022 - 2030
9.2.6.5.5.
Latin
America
9.2.6.5.5.1. Market Estimation, 2015 - 2021
9.2.6.5.5.2. Market Forecast, 2022 - 2030
9.3.
Key
Segment for Channeling Investments
9.3.1.
By Diagnosis/imaging techniques
10. Global Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
10.2.1. Hospitals
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 -
2021
10.2.1.3. Market Forecast, 2022 - 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Clinics
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 -
2021
10.2.2.3. Market Forecast, 2022 - 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Diagnostic centers
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 -
2021
10.2.3.3. Market Forecast, 2022 - 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 -
2021
10.2.4.3. Market Forecast, 2022 - 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 - 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 - 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 - 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By End Users
11. North America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030
11.1. Overview
11.1.1. North America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn)
11.2. North America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
11.2.1. Stent
11.2.2. PTA Balloon Catheter
11.3. North America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
11.3.1. High Definition MRI
11.3.2. Balloon test occlusion
11.3.3. Computed tomographic angiogram (CTA)
11.3.4. Transcranial Doppler ultrasound (TCD)
11.3.5. Digital subtraction angiography (DSA)
11.3.6. Others
11.4. North America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostic centers
11.4.4. Others
11.5. North America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.1.1.1. Stent
11.5.1.1.2. PTA Balloon Catheter
11.5.1.2. U.S Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
11.5.1.2.1. High Definition MRI
11.5.1.2.2. Balloon test occlusion
11.5.1.2.3. Computed tomographic angiogram (CTA)
11.5.1.2.4. Transcranial Doppler ultrasound (TCD)
11.5.1.2.5. Digital subtraction angiography (DSA)
11.5.1.2.6. Others
11.5.1.3. U.S Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.1.3.1. Hospitals
11.5.1.3.2. Clinics
11.5.1.3.3. Diagnostic centers
11.5.1.3.4. Others
11.5.2. Canada
11.5.2.1. Canada Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.2.1.1. Stent
11.5.2.1.2. PTA Balloon Catheter
11.5.2.2. Canada Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
11.5.2.2.1. High Definition MRI
11.5.2.2.2. Balloon test occlusion
11.5.2.2.3. Computed tomographic angiogram (CTA)
11.5.2.2.4. Transcranial Doppler ultrasound (TCD)
11.5.2.2.5. Digital subtraction angiography (DSA)
11.5.2.2.6. Others
11.5.2.3. Canada Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.2.3.1. Hospitals
11.5.2.3.2. Clinics
11.5.2.3.3. Diagnostic centers
11.5.2.3.4. Others
11.5.3. Mexico
11.5.3.1. Mexico Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.3.1.1. Stent
11.5.3.1.2. PTA Balloon Catheter
11.5.3.2. Mexico Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
11.5.3.2.1. High Definition MRI
11.5.3.2.2. Balloon test occlusion
11.5.3.2.3. Computed tomographic angiogram (CTA)
11.5.3.2.4. Transcranial Doppler ultrasound (TCD)
11.5.3.2.5. Digital subtraction angiography (DSA)
11.5.3.2.6. Others
11.5.3.3. Mexico Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.3.3.1. Hospitals
11.5.3.3.2. Clinics
11.5.3.3.3. Diagnostic centers
11.5.3.3.4. Others
11.5.4. Rest of North America
11.5.4.1. Rest of North America Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Product Type
11.5.4.1.1. Stent
11.5.4.1.2. PTA Balloon Catheter
11.5.4.2. Rest of North America Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Diagnosis/imaging techniques
11.5.4.2.1. High Definition MRI
11.5.4.2.2. Balloon test occlusion
11.5.4.2.3. Computed tomographic angiogram (CTA)
11.5.4.2.4. Transcranial Doppler ultrasound (TCD)
11.5.4.2.5. Digital subtraction angiography (DSA)
11.5.4.2.6. Others
11.5.4.3. Rest of North America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.4.3.1. Hospitals
11.5.4.3.2. Clinics
11.5.4.3.3. Diagnostic centers
11.5.4.3.4. Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By
Diagnosis/imaging techniques
11.6.4. By End Users
12. Europe Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030
12.1. Overview
12.1.1. Europe Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn)
12.2. Europe Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.2.1. Stent
12.2.2. PTA Balloon Catheter
12.3. Europe Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.3.1. High Definition MRI
12.3.2. Balloon test occlusion
12.3.3. Computed tomographic angiogram (CTA)
12.3.4. Transcranial Doppler ultrasound (TCD)
12.3.5. Digital subtraction angiography (DSA)
12.3.6. Others
12.4. Europe Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostic centers
12.4.4. Others
12.5. Europe Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.1.1.1. Stent
12.5.1.1.2. PTA Balloon Catheter
12.5.1.2. France Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.5.1.2.1. High Definition MRI
12.5.1.2.2. Balloon test occlusion
12.5.1.2.3. Computed tomographic angiogram (CTA)
12.5.1.2.4. Transcranial Doppler ultrasound (TCD)
12.5.1.2.5. Digital subtraction angiography (DSA)
12.5.1.2.6. Others
12.5.1.3. France Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1.3.1. Hospitals
12.5.1.3.2. Clinics
12.5.1.3.3. Diagnostic centers
12.5.1.3.4. Others
12.5.2. The UK
12.5.2.1. The UK Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.2.1.1. Stent
12.5.2.1.2. PTA Balloon Catheter
12.5.2.2. The UK Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.5.2.2.1. High Definition MRI
12.5.2.2.2. Balloon test occlusion
12.5.2.2.3. Computed tomographic angiogram (CTA)
12.5.2.2.4. Transcranial Doppler ultrasound (TCD)
12.5.2.2.5. Digital subtraction angiography (DSA)
12.5.2.2.6. Others
12.5.2.3. The UK Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.2.3.1. Hospitals
12.5.2.3.2. Clinics
12.5.2.3.3. Diagnostic centers
12.5.2.3.4. Others
12.5.3. Spain
12.5.3.1. Spain Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.3.1.1. Stent
12.5.3.1.2. PTA Balloon Catheter
12.5.3.2. Spain Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.5.3.2.1. High Definition MRI
12.5.3.2.2. Balloon test occlusion
12.5.3.2.3. Computed tomographic angiogram (CTA)
12.5.3.2.4. Transcranial Doppler ultrasound (TCD)
12.5.3.2.5. Digital subtraction angiography (DSA)
12.5.3.2.6. Others
12.5.3.3. Spain Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.3.3.1. Hospitals
12.5.3.3.2. Clinics
12.5.3.3.3. Diagnostic centers
12.5.3.3.4. Others
12.5.4. Germany
12.5.4.1. Germany Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.4.1.1. Stent
12.5.4.1.2. PTA Balloon Catheter
12.5.4.2. Germany Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.5.4.2.1. High Definition MRI
12.5.4.2.2. Balloon test occlusion
12.5.4.2.3. Computed tomographic angiogram (CTA)
12.5.4.2.4. Transcranial Doppler ultrasound (TCD)
12.5.4.2.5. Digital subtraction angiography (DSA)
12.5.4.2.6. Others
12.5.4.3. Germany Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.4.3.1. Hospitals
12.5.4.3.2. Clinics
12.5.4.3.3. Diagnostic centers
12.5.4.3.4. Others
12.5.5. Italy
12.5.5.1. Italy Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.5.1.1. Stent
12.5.5.1.2. PTA Balloon Catheter
12.5.5.2. Italy Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.5.5.2.1. High Definition MRI
12.5.5.2.2. Balloon test occlusion
12.5.5.2.3. Computed tomographic angiogram (CTA)
12.5.5.2.4. Transcranial Doppler ultrasound (TCD)
12.5.5.2.5. Digital subtraction angiography (DSA)
12.5.5.2.6. Others
12.5.5.3. Italy Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.5.3.1. Hospitals
12.5.5.3.2. Clinics
12.5.5.3.3. Diagnostic centers
12.5.5.3.4. Others
12.5.6. Nordic Countries
12.5.6.1. Nordic Countries Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.6.1.1. Stent
12.5.6.1.2. PTA Balloon Catheter
12.5.6.2. Nordic Countries Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.5.6.2.1. High Definition MRI
12.5.6.2.2. Balloon test occlusion
12.5.6.2.3. Computed tomographic angiogram (CTA)
12.5.6.2.4. Transcranial Doppler ultrasound (TCD)
12.5.6.2.5. Digital subtraction angiography (DSA)
12.5.6.2.6. Others
12.5.6.3. Nordic Countries Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.6.3.1. Hospitals
12.5.6.3.2. Clinics
12.5.6.3.3. Diagnostic centers
12.5.6.3.4. Others
12.5.6.4. Nordic Countries Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux Union
12.5.7.1. Benelux Union Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.7.1.1. Stent
12.5.7.1.2. PTA Balloon Catheter
12.5.7.2. Benelux Union Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.5.7.2.1. High Definition MRI
12.5.7.2.2. Balloon test occlusion
12.5.7.2.3. Computed tomographic angiogram (CTA)
12.5.7.2.4. Transcranial Doppler ultrasound (TCD)
12.5.7.2.5. Digital subtraction angiography (DSA)
12.5.7.2.6. Others
12.5.7.3. Benelux Union Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.7.3.1. Hospitals
12.5.7.3.2. Clinics
12.5.7.3.3. Diagnostic centers
12.5.7.3.4. Others
12.5.7.4. Benelux Union Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of Europe
12.5.8.1. Rest of Europe Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.8.1.1. Stent
12.5.8.1.2. PTA Balloon Catheter
12.5.8.2. Rest of Europe Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
12.5.8.2.1. High Definition MRI
12.5.8.2.2. Balloon test occlusion
12.5.8.2.3. Computed tomographic angiogram (CTA)
12.5.8.2.4. Transcranial Doppler ultrasound (TCD)
12.5.8.2.5. Digital subtraction angiography (DSA)
12.5.8.2.6. Others
12.5.8.3. Rest of Europe Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.8.3.1. Hospitals
12.5.8.3.2. Clinics
12.5.8.3.3. Diagnostic centers
12.5.8.3.4. Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Product Type
12.6.3. By
Diagnosis/imaging techniques
12.6.4. By End Users
13. Asia Pacific Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Asia Pacific Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn)
13.2. Asia Pacific Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
13.2.1. Stent
13.2.2. PTA Balloon Catheter
13.3. Asia Pacific Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
13.3.1. High Definition MRI
13.3.2. Balloon test occlusion
13.3.3. Computed tomographic angiogram (CTA)
13.3.4. Transcranial Doppler ultrasound (TCD)
13.3.5. Digital subtraction angiography (DSA)
13.3.6. Others
13.4. Asia Pacific Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostic centers
13.4.4. Others
13.5. Asia Pacific Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.1.1.1. Stent
13.5.1.1.2. PTA Balloon Catheter
13.5.1.2. China Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
13.5.1.2.1. High Definition MRI
13.5.1.2.2. Balloon test occlusion
13.5.1.2.3. Computed tomographic angiogram (CTA)
13.5.1.2.4. Transcranial Doppler ultrasound (TCD)
13.5.1.2.5. Digital subtraction angiography (DSA)
13.5.1.2.6. Others
13.5.1.3. China Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1.3.1. Hospitals
13.5.1.3.2. Clinics
13.5.1.3.3. Diagnostic centers
13.5.1.3.4. Others
13.5.2. Japan
13.5.2.1. Japan Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.2.1.1. Stent
13.5.2.1.2. PTA Balloon Catheter
13.5.2.2. Japan Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
13.5.2.2.1. High Definition MRI
13.5.2.2.2. Balloon test occlusion
13.5.2.2.3. Computed tomographic angiogram (CTA)
13.5.2.2.4. Transcranial Doppler ultrasound (TCD)
13.5.2.2.5. Digital subtraction angiography (DSA)
13.5.2.2.6. Others
13.5.2.3. Japan Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.2.3.1. Hospitals
13.5.2.3.2. Clinics
13.5.2.3.3. Diagnostic centers
13.5.2.3.4. Others
13.5.3. India
13.5.3.1. India Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.3.1.1. Stent
13.5.3.1.2. PTA Balloon Catheter
13.5.3.2. India Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
13.5.3.2.1. High Definition MRI
13.5.3.2.2. Balloon test occlusion
13.5.3.2.3. Computed tomographic angiogram (CTA)
13.5.3.2.4. Transcranial Doppler ultrasound (TCD)
13.5.3.2.5. Digital subtraction angiography (DSA)
13.5.3.2.6. Others
13.5.3.3. India Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.3.3.1. Hospitals
13.5.3.3.2. Clinics
13.5.3.3.3. Diagnostic centers
13.5.3.3.4. Others
13.5.4. New Zealand
13.5.4.1. New Zealand Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.4.1.1. Stent
13.5.4.1.2. PTA Balloon Catheter
13.5.4.2. New Zealand Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
13.5.4.2.1. High Definition MRI
13.5.4.2.2. Balloon test occlusion
13.5.4.2.3. Computed tomographic angiogram (CTA)
13.5.4.2.4. Transcranial Doppler ultrasound (TCD)
13.5.4.2.5. Digital subtraction angiography (DSA)
13.5.4.2.6. Others
13.5.4.3. New Zealand Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.4.3.1. Hospitals
13.5.4.3.2. Clinics
13.5.4.3.3. Diagnostic centers
13.5.4.3.4. Others
13.5.5. Australia
13.5.5.1. Australia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.5.1.1. Stent
13.5.5.1.2. PTA Balloon Catheter
13.5.5.2. Australia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
13.5.5.2.1. High Definition MRI
13.5.5.2.2. Balloon test occlusion
13.5.5.2.3. Computed tomographic angiogram (CTA)
13.5.5.2.4. Transcranial Doppler ultrasound (TCD)
13.5.5.2.5. Digital subtraction angiography (DSA)
13.5.5.2.6. Others
13.5.5.3. Australia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.5.3.1. Hospitals
13.5.5.3.2. Clinics
13.5.5.3.3. Diagnostic centers
13.5.5.3.4. Others
13.5.6. South Korea
13.5.6.1. South Korea Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.6.1.1. Stent
13.5.6.1.2. PTA Balloon Catheter
13.5.6.2. South Korea Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
13.5.6.2.1. High Definition MRI
13.5.6.2.2. Balloon test occlusion
13.5.6.2.3. Computed tomographic angiogram (CTA)
13.5.6.2.4. Transcranial Doppler ultrasound (TCD)
13.5.6.2.5. Digital subtraction angiography (DSA)
13.5.6.2.6. Others
13.5.6.3. South Korea Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.6.3.1. Hospitals
13.5.6.3.2. Clinics
13.5.6.3.3. Diagnostic centers
13.5.6.3.4. Others
13.5.7. Southeast Asia
13.5.7.1. Southeast Asia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.7.1.1. Stent
13.5.7.1.2. PTA Balloon Catheter
13.5.7.2. Southeast Asia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
13.5.7.2.1. High Definition MRI
13.5.7.2.2. Balloon test occlusion
13.5.7.2.3. Computed tomographic angiogram (CTA)
13.5.7.2.4. Transcranial Doppler ultrasound (TCD)
13.5.7.2.5. Digital subtraction angiography (DSA)
13.5.7.2.6. Others
13.5.7.3. Southeast Asia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.7.3.1. Hospitals
13.5.7.3.2. Clinics
13.5.7.3.3. Diagnostic centers
13.5.7.3.4. Others
13.5.7.4. Southeast Asia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1. Rest of Asia Pacific Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Product Type
13.5.8.1.1. Stent
13.5.8.1.2. PTA Balloon Catheter
13.5.8.2. Rest of Asia Pacific Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Diagnosis/imaging techniques
13.5.8.2.1. High Definition MRI
13.5.8.2.2. Balloon test occlusion
13.5.8.2.3. Computed tomographic angiogram (CTA)
13.5.8.2.4. Transcranial Doppler ultrasound (TCD)
13.5.8.2.5. Digital subtraction angiography (DSA)
13.5.8.2.6. Others
13.5.8.3. Rest of Asia Pacific Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
13.5.8.3.1. Hospitals
13.5.8.3.2. Clinics
13.5.8.3.3. Diagnostic centers
13.5.8.3.4. Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Product Type
13.6.3. By
Diagnosis/imaging techniques
13.6.4. By End Users
14. Middle East and Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 -
2030
14.1. Overview
14.1.1. Middle East and Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn)
14.2. Middle East and Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Product Type
14.2.1. Stent
14.2.2. PTA Balloon Catheter
14.3. Middle East and Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Diagnosis/imaging techniques
14.3.1. High Definition MRI
14.3.2. Balloon test occlusion
14.3.3. Computed tomographic angiogram (CTA)
14.3.4. Transcranial Doppler ultrasound (TCD)
14.3.5. Digital subtraction angiography (DSA)
14.3.6. Others
14.4. Middle East and Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Diagnostic centers
14.4.4. Others
14.5. Middle East and Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Country
14.5.1. Saudi Arabia
14.5.1.1. Saudi Arabia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.1.1.1. Stent
14.5.1.1.2. PTA Balloon Catheter
14.5.1.2. Saudi Arabia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
14.5.1.2.1. High Definition MRI
14.5.1.2.2. Balloon test occlusion
14.5.1.2.3. Computed tomographic angiogram (CTA)
14.5.1.2.4. Transcranial Doppler ultrasound (TCD)
14.5.1.2.5. Digital subtraction angiography (DSA)
14.5.1.2.6. Others
14.5.1.3. Saudi Arabia Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1.3.1. Hospitals
14.5.1.3.2. Clinics
14.5.1.3.3. Diagnostic centers
14.5.1.3.4. Others
14.5.2. UAE
14.5.2.1. UAE Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.2.1.1. Stent
14.5.2.1.2. PTA Balloon Catheter
14.5.2.2. UAE Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
14.5.2.2.1. High Definition MRI
14.5.2.2.2. Balloon test occlusion
14.5.2.2.3. Computed tomographic angiogram (CTA)
14.5.2.2.4. Transcranial Doppler ultrasound (TCD)
14.5.2.2.5. Digital subtraction angiography (DSA)
14.5.2.2.6. Others
14.5.2.3. UAE Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.2.3.1. Hospitals
14.5.2.3.2. Clinics
14.5.2.3.3. Diagnostic centers
14.5.2.3.4. Others
14.5.3. Egypt
14.5.3.1. Egypt Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.3.1.1. Stent
14.5.3.1.2. PTA Balloon Catheter
14.5.3.2. Egypt Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
14.5.3.2.1. High Definition MRI
14.5.3.2.2. Balloon test occlusion
14.5.3.2.3. Computed tomographic angiogram (CTA)
14.5.3.2.4. Transcranial Doppler ultrasound (TCD)
14.5.3.2.5. Digital subtraction angiography (DSA)
14.5.3.2.6. Others
14.5.3.3. Egypt Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.3.3.1. Hospitals
14.5.3.3.2. Clinics
14.5.3.3.3. Diagnostic centers
14.5.3.3.4. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.4.1.1. Stent
14.5.4.1.2. PTA Balloon Catheter
14.5.4.2. Kuwait Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
14.5.4.2.1. High Definition MRI
14.5.4.2.2. Balloon test occlusion
14.5.4.2.3. Computed tomographic angiogram (CTA)
14.5.4.2.4. Transcranial Doppler ultrasound (TCD)
14.5.4.2.5. Digital subtraction angiography (DSA)
14.5.4.2.6. Others
14.5.4.3. Kuwait Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.4.3.1. Hospitals
14.5.4.3.2. Clinics
14.5.4.3.3. Diagnostic centers
14.5.4.3.4. Others
14.5.5. South Africa
14.5.5.1. South Africa Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.5.1.1. Stent
14.5.5.1.2. PTA Balloon Catheter
14.5.5.2. South Africa Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
14.5.5.2.1. High Definition MRI
14.5.5.2.2. Balloon test occlusion
14.5.5.2.3. Computed tomographic angiogram (CTA)
14.5.5.2.4. Transcranial Doppler ultrasound (TCD)
14.5.5.2.5. Digital subtraction angiography (DSA)
14.5.5.2.6. Others
14.5.5.3. South Africa Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.5.3.1. Hospitals
14.5.5.3.2. Clinics
14.5.5.3.3. Diagnostic centers
14.5.5.3.4. Others
14.5.6. Rest of Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Product Type
14.5.6.1.1. Stent
14.5.6.1.2. PTA Balloon Catheter
14.5.6.2. Rest of Middle East & Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Diagnosis/imaging techniques
14.5.6.2.1. High Definition MRI
14.5.6.2.2. Balloon test occlusion
14.5.6.2.3. Computed tomographic angiogram (CTA)
14.5.6.2.4. Transcranial Doppler ultrasound (TCD)
14.5.6.2.5. Digital subtraction angiography (DSA)
14.5.6.2.6. Others
14.5.6.3. Rest of Middle East & Africa Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
14.5.6.3.1. Hospitals
14.5.6.3.2. Clinics
14.5.6.3.3. Diagnostic centers
14.5.6.3.4. Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Product Type
14.6.3. By
Diagnosis/imaging techniques
14.6.4. By End Users
15. Latin America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Latin America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn)
15.2. Latin America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
15.2.1. Stent
15.2.2. PTA Balloon Catheter
15.3. Latin America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
15.3.1. High Definition MRI
15.3.2. Balloon test occlusion
15.3.3. Computed tomographic angiogram (CTA)
15.3.4. Transcranial Doppler ultrasound (TCD)
15.3.5. Digital subtraction angiography (DSA)
15.3.6. Others
15.4. Latin America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
15.4.1. Hospitals
15.4.2. Clinics
15.4.3. Diagnostic centers
15.4.4. Others
15.5. Latin America Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
15.5.1.1.1. Stent
15.5.1.1.2. PTA Balloon Catheter
15.5.1.2. Brazil Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
15.5.1.2.1. High Definition MRI
15.5.1.2.2. Balloon test occlusion
15.5.1.2.3. Computed tomographic angiogram (CTA)
15.5.1.2.4. Transcranial Doppler ultrasound (TCD)
15.5.1.2.5. Digital subtraction angiography (DSA)
15.5.1.2.6. Others
15.5.1.3. Brazil Intracranial Atherosclerotic Disease
(ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1.3.1. Hospitals
15.5.1.3.2. Clinics
15.5.1.3.3. Diagnostic centers
15.5.1.3.4. Others
15.5.2. Argentina
15.5.2.1. Argentina Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Product Type
15.5.2.1.1. Stent
15.5.2.1.2. PTA Balloon Catheter
15.5.2.2. Argentina Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By Diagnosis/imaging techniques
15.5.2.2.1. High Definition MRI
15.5.2.2.2. Balloon test occlusion
15.5.2.2.3. Computed tomographic angiogram (CTA)
15.5.2.2.4. Transcranial Doppler ultrasound (TCD)
15.5.2.2.5. Digital subtraction angiography (DSA)
15.5.2.2.6. Others
15.5.2.3. Argentina Intracranial Atherosclerotic
Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.2.3.1. Hospitals
15.5.2.3.2. Clinics
15.5.2.3.3. Diagnostic centers
15.5.2.3.4. Others
15.5.3. Rest of Latin America
15.5.3.1. Rest of Latin America Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Product Type
15.5.3.1.1. Stent
15.5.3.1.2. PTA Balloon Catheter
15.5.3.2. Rest of Latin America Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By Diagnosis/imaging techniques
15.5.3.2.1. High Definition MRI
15.5.3.2.2. Balloon test occlusion
15.5.3.2.3. Computed tomographic angiogram (CTA)
15.5.3.2.4. Transcranial Doppler ultrasound (TCD)
15.5.3.2.5. Digital subtraction angiography (DSA)
15.5.3.2.6. Others
15.5.3.3. Rest of Latin America Intracranial
Atherosclerotic Disease (ICAD) Pathology Market Revenue (US$ Mn) and Forecasts,
By End Users
15.5.3.3.1. Hospitals
15.5.3.3.2. Clinics
15.5.3.3.3. Diagnostic centers
15.5.3.3.4. Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Product Type
15.6.3. By
Diagnosis/imaging techniques
15.6.4. By End Users
16. Competitive Benchmarking
16.1. Brand Benchmarking
16.2. Market Share Analysis, 2021
16.3. Global Presence and Growth Strategies
16.3.1. Mergers and Acquisitions
16.3.2. Product Launches
16.3.3. Investments Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Acandis GmbH
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. BALT group
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. Boston Scientific Corporation
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. CERENOVUS
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. Medtronic
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. MicroPort Scientific Corporation
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. Stryker
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business Strategies
17.8. Terumo Corporation
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7.
Business
Strategies
17.9. Other Market Participants
18. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
![AMI AMI](https://www.absolutemarketsinsights.com/upload/Research_Scope2.jpg)
![AMI AMI](https://www.absolutemarketsinsights.com/upload/Global_IMG2.jpg)
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.
![AMI AMI](https://www.absolutemarketsinsights.com/images/iso_form.jpg)